October 16-17: Applying RWD and Novel Data Sources to Advance Patient-Centric Health Equity, Outcomes, and Economic Evaluations- Virtual
event-Short-Courses

October 16, 2024 - October 17, 2024

Back to all short courses

Applying RWD and Novel Data Sources to Advance Patient-Centric Health Equity, Outcomes, and Economic Evaluations- Virtual

LEVEL: Introductory
TRACK:
Real World Data & Information Systems
LENGTH:
4 Hours | Course runs 2 consecutive days, 2 hours each day

Register Here

Wednesday, 16 October 2024 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM–16:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Summer Time (CEST)

Thursday, 17 October 2024 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM–16:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Summer Time (CEST)

DESCRIPTION
Precision medicine and next-generation therapeutics have tremendous opportunity for accelerated speed-to-market through the generation of real-world evidence (RWE). Patient-centric, whole person care requires a holistic understanding outside of the clinical-trial environment, including longitudinal health history and social and environment context. Furthermore, given the FDA’s 2022 guidance on increasing diversity in clinical trials, we must also ensure that any real-world evidence represents a diverse and equitable population, to generate outcomes and patient care standards that are generalizable and representative of the full population. Many RWD/RWE researchers rely on low resolution zip code or payer type figures to monitor the diversity of the dataset. However, this data lacks important variables specific to evaluating health equity, such as access to care and transportation, income inequality, and household and social supports.

This course will provide participants with insights on novel data sources, such as consumer data, that can provide holistic insights into health equity and social drivers of health. We will cover how this data can be integrated with additional data sources, including clinical or medical claims data, and effectively de-identified for HIPAA compliant research-ready analysis. Lastly, we will provide examples of how this comprehensive, patient-centered data accelerates epidemiology research, patient journey analytics, and clinical trial design. Traditional approaches implementing RWD/RWE into decision making, along with their limitations will be explored during this course. Finally, perspective on innovative approaches to mitigating the risks of ambiguous inference and leaving important populations out of next generation research will be offered.

PREREQUISITE: Participants must understand social determinants, confounding, inference, basic research methods, and traditional care pathways.

Faculty

Camille Cook, MPH
Sr. Director Healthcare Strategy RWD
LexisNexis Risk Solutions
Alpharetta, GA, USA

Molli Sanocki, PhD
Sr. Director Healthcare Analytics
LexisNexis Risk Solutions
Alpharetta, GA, USA

 

Basic Schedule:

4 Hours | Course runs 2 consecutive days, 2 hours each day

ISPOR short courses are designed to enhance knowledge and techniques in core health economics and outcomes research (HEOR) topics as well as emerging trends in the field. Short courses offer 4 or 8 hours of premium scientific education and an electronic course book. Active attendee participation combined with our expert faculty creates an immersive and impactful virtual learning experience. Short courses are not recorded and are only available during the live broadcast.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×